Combined treatment with recombinant tissue plasminogen activator and dexamethasone phosphate-containing liposomes improves neurological outcome and restricts lesion progression after embolic stroke in rats

Macrophages and liposomes in inflammatory disease: Friends or foes?

(2011) B.J. Crielaard et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Drug targeting systems for inflammatory disease: One for all, all for one

(2011) Bart J. Crielaard et al.   JOURNAL OF CONTROLLED RELEASE

The Concept of the Penumbra: can it be Translated to Stroke Management?

(2010) Wolf-Dieter Heiss   International Journal of Stroke

Multimodal Clinical Imaging To Longitudinally Assess a Nanomedical Anti-Inflammatory Treatment in Experimental Atherosclerosis

(2010) Mark E. Lobatto et al.   MOLECULAR PHARMACEUTICS

Predicting tissue outcome in stroke: new approaches

(2009) Leif Østergaard et al.   CURRENT OPINION IN NEUROLOGY

elastix: A Toolbox for Intensity-Based Medical Image Registration

(2009) S. Klein et al.   IEEE TRANSACTIONS ON MEDICAL IMAGING

Longitudinal in vivo MRI of alterations in perilesional tissue after transient ischemic stroke in rats

(2008) Jet P. van der Zijden et al.   EXPERIMENTAL NEUROLOGY

Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

(2008) Werner Hacke et al.   NEW ENGLAND JOURNAL OF MEDICINE

MRI Detection of Early Blood-Brain Barrier Disruption

(2008) Niels Hjort et al.   STROKE

Good Laboratory Practice

(2008) Malcolm R. Macleod et al.   STROKE

Dexamethasone reduces food intake, weight gain and the hypothalamic 5-HT concentration and increases plasma leptin in rats

(2007) Jeong Won Jahng et al.   EUROPEAN JOURNAL OF PHARMACOLOGY